Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes.
Papalexandri A, Gavriilaki E, Vardi A, Kotsiou N, Demosthenous C, Constantinou N, Touloumenidou T, Zerva P, Kika F, Iskas M, Batsis I, Mallouri D, Yannaki E, Anagnostopoulos A, Sakellari I.
Papalexandri A, et al. Among authors: constantinou n.
Int J Mol Sci. 2023 Nov 7;24(22):16029. doi: 10.3390/ijms242216029.
Int J Mol Sci. 2023.
PMID: 38003218
Free PMC article.